Funder
European Social Fund
Instituto de Salud Carlos III
Universidad Autónoma de Madrid
CIBERehd
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference16 articles.
1. Moon W, Loftus EV. Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2016;43:863–83.
2. Zaza G, Cheok M, Krynetskaia N, et al. Thiopurine pathway. Pharmacogenet Genom. 2010;20:573–4.
3. Peng X-X, Shi Z, Damaraju VL, et al. Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine. Leuk Res. 2008;32:799–809.
4. Abaji R, Krajinovic M. Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response. Pharmgenomics Pers Med. 2017;10:143–56.
5. Zalizko P, Stefanovics J, Sokolovska J, et al. Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population. Ther Adv Gastroenterol. 2020;13:175628482093742.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献